Institute of Clinical Medicine - Neurology, University of Eastern Finland, Yliopistonranta 1C, FI-70210 Kuopio, Finland.
Cell Mol Life Sci. 2011 Sep;68(18):3007-17. doi: 10.1007/s00018-011-0733-3. Epub 2011 May 29.
Valid experimental models and behavioral tests are indispensable for the development of therapies for stroke. The translational failure with neuroprotective drugs has forced us to look for alternative approaches. Restorative therapies aiming to facilitate the recovery process by pharmacotherapy or cell-based therapy have emerged as promising options. Here we describe the most common stroke models used in cell-based therapy studies with particular emphasis on their inherent complications, which may affect behavioral outcome. Loss of body weight, stress, hyperthermia, immunodepression, and infections particularly after severe transient middle cerebral artery occlusion (filament model) are recognized as possible confounders to impair performance in certain behavioral tasks and bias the treatment effects. Inherent limitations of stroke models should be carefully considered when planning experiments to ensure translation of behavioral data to the clinic.
有效的实验模型和行为测试对于开发中风治疗方法是必不可少的。神经保护药物的转化失败迫使我们寻找替代方法。旨在通过药物治疗或细胞治疗来促进恢复过程的修复疗法已成为有前途的选择。在这里,我们描述了细胞治疗研究中最常用的中风模型,特别强调了它们可能影响行为结果的固有并发症。体重减轻、应激、体温过高、免疫抑制以及感染(特别是在严重短暂性大脑中动脉闭塞后)被认为是某些行为任务表现受损和治疗效果产生偏差的可能混杂因素。在计划实验时,应仔细考虑中风模型的固有局限性,以确保行为数据向临床的转化。